TP53 and lung cancer: We also performed a limited number of studies in the conditional KrasG12D/Trp53 mouse lung cancer model, with activation of the endogenous KRAS-G12D mutation and disruption of p53 by inhalation of an adenovirus vector encoding the Cre recombinase (Fig. 8a–d).